Department of Medical Oncology, Institute of Oncology, Istanbul University, Istanbul, Turkey,
Department of Internal Medicine, Division of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey,
Chemotherapy. 2020;65(5-6):141-146. doi: 10.1159/000511884. Epub 2020 Dec 4.
The novel coronavirus disease 2019 has become a worldwide threat. We aimed to explore reflections of these unexpected changes to newly diagnosed cancer patients.
We searched the 2 months after the index case of our country. The first admission day and the first day of intravenous treatment of newly diagnosed patients were recorded.
In the 60 days measured during the pandemic, the total number of patients on polyclinics was 159/weekdays, and the total applied chemotherapy cycles were 276/week. For comparison, the total numbers in the previous year were 267/weekday and 363/week for polyclinic and applied chemotherapy cycles, respectively. The total number of newly admitted patients in 2020 was 283. For comparison, the number of new patients in the same 60-day period in 2019 was 495. Patients who were admitted for adjuvant treatment required a median of 8 days for the first course, those who were admitted for neoadjuvant treatment required 12 days, and metastatic patients required 14 days; there were no significant differences between treatment types (p = 0.233). However, the median treatment time was 11.5 and 17 days, in 2020 and in 2019, respectively. A significant difference was observed between the 2 groups (p < 0.001).
The effective shift of workers and accurate regulations have not resulted in apparent delays in patient care. While a decrease in the number of patients has detected, faster healthcare service was introduced to newly diagnosed patients. The reason for the decrease in the number of patients should be investigated with new studies.
2019 年新型冠状病毒病已成为全球性威胁。我们旨在探讨这些意外变化对新诊断癌症患者的影响。
我们检索了我国首例病例后的 2 个月。记录新诊断患者的首次入院日和静脉治疗的第一天。
在疫情期间测量的 60 天内，门诊部的患者总数为每周 159 人，应用的化疗周期总数为每周 276 个。相比之下，前一年的总数分别为每周 267 人和每周 363 个化疗周期。2020 年新入院患者总数为 283 人。相比之下，2019 年同期的新患者人数为 495 人。辅助治疗入院的患者第一疗程中位数为 8 天，新辅助治疗入院的患者为 12 天，转移性患者为 14 天；不同治疗类型之间无显著差异（p = 0.233）。然而，2020 年和 2019 年的中位治疗时间分别为 11.5 天和 17 天。两组之间存在显著差异（p < 0.001）。
工人的有效转移和准确的规定并没有导致患者护理明显延迟。虽然检测到患者数量减少，但为新诊断患者引入了更快的医疗服务。应该用新的研究来调查患者数量减少的原因。
